New Alzheimer’s drug trial at R.I. Hospital a source of comfort for some participants

SILENT ONSET: Dr. Jonathan Drake, associate director of the Alzheimer’s Disease and Memory Disorders Center at Rhode Island Hospital, says Alzheimer’s develops decades before a person shows the first ­symptoms. / PBN PHOTO/ELIZABETH GRAHAM
SILENT ONSET: Dr. Jonathan Drake, associate director of the Alzheimer’s Disease and Memory Disorders Center at Rhode Island Hospital, says Alzheimer’s develops decades before a person shows the first ­symptoms. / PBN PHOTO/ELIZABETH GRAHAM
Brightly colored images of a patient’s brain, taken with a specialized scan, glow on Dr. Jonathan Drake’s computer screen as he points out deposits of a substance that’s associated with Alzheimer’s disease. Amyloid plaque is toxic, and buildups of the protein in the brain are almost always associated with an Alzheimer’s diagnosis. As associate director…

Subscriber Only

Subscribe with Providence Business News to keep reading.

Get unlimited access now for $1 for 4 weeks

Subscribe now for $1
Already a Subscriber? Login now

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.

- Advertisement -

No posts to display